Comparative Pharmacology
Head-to-head clinical analysis: FLEQSUVY versus LINDANE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FLEQSUVY versus LINDANE.
FLEQSUVY vs LINDANE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
FLEQSUVY (fosfomycin tromethamine) is a bactericidal antibiotic that inhibits bacterial cell wall synthesis by inactivating the enzyme UDP-N-acetylglucosamine-3-enolpyruvyltransferase (MurA), which catalyzes the first step of peptidoglycan biosynthesis.
Lindane is an organochlorine insecticide that acts by binding to the GABA-A receptor, inhibiting chloride ion influx, leading to hyperexcitation and death of arthropods. It also blocks voltage-gated sodium channels in neurons.
500 mg orally twice daily, preferably with food.
Scabies: Apply 1% lotion or cream thinly to entire body from neck to toes; leave on for 8-12 hours, then wash off. Lice: Apply 1% shampoo to dry hair, lather with water, leave for 4 minutes, then rinse; repeat in 7 days if needed.
None Documented
None Documented
Terminal elimination half-life is approximately 12 hours (range 10–14 hours) in healthy adults. This supports once-daily dosing in most patients.
Terminal half-life: 18-21 hours in adults; prolonged in obesity (up to 30-40 hours) due to adipose storage. Accumulation occurs with repeated dermal applications.
Primarily renal excretion as unchanged drug (approximately 70%). Fecal elimination accounts for roughly 20%, with less than 5% as metabolites.
Primarily renal; ~50% as metabolites (conjugated and oxidized), <20% unchanged. Fecal excretion accounts for ~10-15% via biliary elimination. Small amounts excreted in sweat.
Category C
Category C
Pediculicide
Scabicide/Pediculicide